Neogen Chemicals [NEOGEN] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison

Neogen Chemicals
NSE
Loading...

Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Neogen Chemicals wins in 7 metrics, Grauer & Weil wins in 13 metrics, with 0 ties. Grauer & Weil appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Neogen Chemicals | Grauer & Weil | Better |
---|---|---|---|
P/E Ratio (TTM) | 111.20 | 27.77 | Grauer & Weil |
Price-to-Book Ratio | 4.76 | 4.65 | Grauer & Weil |
Debt-to-Equity Ratio | 75.60 | 1.26 | Grauer & Weil |
PEG Ratio | 44.29 | 38.69 | Grauer & Weil |
EV/EBITDA | 30.85 | 20.47 | Grauer & Weil |
Profit Margin (TTM) | 4.29% | 13.85% | Grauer & Weil |
Operating Margin (TTM) | 13.78% | 7.46% | Neogen Chemicals |
EBITDA Margin (TTM) | 13.78% | 7.46% | Neogen Chemicals |
Return on Equity | 4.41% | 18.02% | Grauer & Weil |
Return on Assets (TTM) | 1.99% | 8.70% | Grauer & Weil |
Free Cash Flow (TTM) | $-1.22B | $999.80M | Grauer & Weil |
Dividend Yield | 0.12% | 1.05% | Grauer & Weil |
1-Year Return | -10.37% | 1.69% | Grauer & Weil |
Price-to-Sales Ratio (TTM) | 4.78 | 3.85 | Grauer & Weil |
Enterprise Value | $43.33B | $38.42B | Neogen Chemicals |
EV/Revenue Ratio | 5.52 | 3.39 | Grauer & Weil |
Gross Profit Margin (TTM) | 45.51% | 41.05% | Neogen Chemicals |
Revenue per Share (TTM) | $297 | $25 | Neogen Chemicals |
Earnings per Share (Diluted) | $12.77 | $3.47 | Neogen Chemicals |
Beta (Stock Volatility) | -0.08 | 0.28 | Neogen Chemicals |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Neogen Chemicals vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Neogen Chemicals | -3.05% | 0.08% | -9.50% | -6.84% | -26.18% | -34.40% |
Grauer & Weil | -3.24% | 1.00% | -8.63% | 14.99% | 3.51% | -8.98% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Neogen Chemicals | -10.37% | -0.91% | 91.66% | 443.71% | 443.71% | 443.71% |
Grauer & Weil | 1.69% | 42.58% | 122.46% | 397.91% | 980.68% | 747.59% |
Performance & Financial Health Analysis: Neogen Chemicals vs Grauer & Weil
Metric | NEOGEN | GRAUWEIL |
---|---|---|
Market Information | ||
Market Cap | ₹37.47B | ₹43.69B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 37,792 | 133,480 |
90 Day Avg. Volume | 26,522 | 191,775 |
Last Close | ₹1,403.40 | ₹92.70 |
52 Week Range | ₹1,392.75 - ₹2,420.00 | ₹78.00 - ₹120.00 |
% from 52W High | -42.01% | -22.75% |
All-Time High | ₹2,420.00 (Dec 09, 2024) | ₹204.80 (Feb 26, 2024) |
% from All-Time High | -42.01% | -54.74% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.04% | 0.02% |
Quarterly Earnings Growth | -0.11% | -0.12% |
Financial Health | ||
Profit Margin (TTM) | 0.04% | 0.14% |
Operating Margin (TTM) | 0.14% | 0.07% |
Return on Equity (TTM) | 0.04% | 0.18% |
Debt to Equity (MRQ) | 75.60 | 1.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹298.07 | ₹20.72 |
Cash per Share (MRQ) | ₹1.88 | ₹11.87 |
Operating Cash Flow (TTM) | ₹645.50M | ₹1.44B |
Levered Free Cash Flow (TTM) | ₹348.30M | ₹927.08M |
Dividends | ||
Last 12-Month Dividend Yield | 0.12% | 1.05% |
Last 12-Month Dividend | ₹2.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Neogen Chemicals vs Grauer & Weil
Metric | NEOGEN | GRAUWEIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 111.20 | 27.77 |
Forward P/E | 44.29 | 38.69 |
PEG Ratio | 44.29 | 38.69 |
Price to Sales (TTM) | 4.78 | 3.85 |
Price to Book (MRQ) | 4.76 | 4.65 |
Market Capitalization | ||
Market Capitalization | ₹37.47B | ₹43.69B |
Enterprise Value | ₹43.33B | ₹38.42B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.52 | 3.39 |
Enterprise to EBITDA | 30.85 | 20.47 |
Risk & Other Metrics | ||
Beta | -0.08 | 0.28 |
Book Value per Share (MRQ) | ₹298.07 | ₹20.72 |
Financial Statements Comparison: Neogen Chemicals vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | NEOGEN | GRAUWEIL |
---|---|---|
Revenue/Sales | ₹2.03B | ₹3.40B |
Cost of Goods Sold | ₹1.08B | ₹2.00B |
Gross Profit | ₹953.20M | ₹1.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹296.20M | ₹237.20M |
EBITDA | ₹229.40M | ₹417.40M |
Pre-Tax Income | ₹36.80M | ₹343.50M |
Income Tax | ₹12.70M | ₹86.10M |
Net Income (Profit) | ₹24.10M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | NEOGEN | GRAUWEIL |
---|---|---|
Cash & Equivalents | ₹49.60M | ₹1.08B |
Total Current Assets | ₹10.00B | ₹9.36B |
Total Current Liabilities | ₹7.33B | ₹2.97B |
Long-Term Debt | ₹1.94B | ₹37.30M |
Total Shareholders Equity | ₹7.89B | ₹9.39B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹4.03B | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | NEOGEN | GRAUWEIL |
---|---|---|
Operating Cash Flow | ₹113.12M | N/A |
Capital Expenditures | ₹-17.15M | N/A |
Free Cash Flow | ₹-3.75M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | NEOGEN | GRAUWEIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 37,792 | 133,480 |
Average Daily Volume (90 Day) | 26,522 | 191,775 |
Shares Outstanding | 26.38M | 453.41M |
Float Shares | 14.50M | 127.47M |
% Held by Insiders | 0.53% | 0.72% |
% Held by Institutions | 0.24% | 0.00% |
Dividend Analysis & Yield Comparison: Neogen Chemicals vs Grauer & Weil
Metric | NEOGEN | GRAUWEIL |
---|---|---|
Last 12-Month Dividend | ₹2.00 | ₹1.00 |
Last 12-Month Dividend Yield | 0.12% | 1.05% |
3-Year Avg Annual Dividend | ₹2.58 | ₹0.58 |
3-Year Avg Dividend Yield | 0.15% | 0.45% |
3-Year Total Dividends | ₹7.75 | ₹1.73 |
Ex-Dividend Date | Sep 19, 2024 | Aug 06, 2025 |